09:30 – 10:00 |
Osler/Long
Room |
|
|
Coffee |
|
|
|
10:00 – 11:00 |
Wolfson Theatre |
|
|
Plenary lecture: Society for Endocrinology Asia and Oceanic Medal Lecture |
|
|
Chair: Bloom
S (London) |
| |
|
|
| S1 |
10:00 |
RNA, proteins and hormone action: tales from down under |
| |
|
Leedman P (Perth, Australia) |
|
|
|
11:00 – 13:00 |
Wolfson Theatre |
|
|
Symposium
1: Zonation of the adrenal cortex – molecular signalling |
| |
|
Chair: Lowry P (Reading) |
| |
|
|
| S5 |
11:00 |
Functional zonation of the adrenal cortex - an overview |
| |
|
Vinson G (London) |
| |
|
|
| S6 |
11:30 |
Wnt signalling in the adrenal cortex |
| |
|
Hornsby P (San Antonio, USA) |
| |
|
|
| S7 |
12:00 |
Adrenomedullin in the adrenal |
| |
|
Hinson J (London) |
| |
|
|
| S8 |
12:30 |
Paracrine regulation of the adrenal cortex |
| |
|
Vaudry H (Rouen, France) |
| |
|
|
| 11:00 – 13:00 |
Sloane/Linacre Room |
| |
|
Oral Communications 1: Growth and development |
| |
|
Chairs: Davis J (Manchester) & Bouloux P (London) |
| |
|
|
| OC1 |
11:00 |
Rat bone marrow mesenchymal stem cells transdifferentiate into islet-secreting
cells in vitro |
| |
|
Jia YJ, Zhou Y, Sun JP, Yang YJ & Dong WW |
| |
|
|
| OC2 |
11:15 |
Insulin
transgene overexpression: a tool for characterisation of beta-cell phenotype
in transdifferentiation studies |
| |
|
Aldibbiat A, Scougall KT, Campbell SC, Macfarlane WM & Shaw
JAM |
| |
|
|
| OC3 |
11:30 |
Cell-cell contact enhances insulin secretion from pancreatic beta-cells
but not glucagon secretion from alpha-cells |
| |
|
Brereton H, Luther MJ, Hauge-Evans AC, Persaud SJ & Jones
PM |
| |
|
|
| *OC4 |
11:45 |
IGF-independent
acceleration of myogenesis by IGFBP-5: modulation of cell survival and
differentiation signalling pathways |
| |
|
Cobb LJ, Gonzalez I, Tripathi G, Lovett FA, Salih DAM, Godwin KS & Pell
JM |
| |
|
|
| *OC5 |
12:00 |
GnRH, anosmin-1 and FGFR1 immunoreactivity in the developing human brain |
| |
|
Gonzalez-Martinez D, Winyard P, Woolf AS & Bouloux PMG |
| |
|
|
| OC6 |
12:15 |
Overexpression of the imprinted gene Neuronatin represses normal pituitary
differentiation |
| |
|
Huerta-Ocampo I, Slack R, Beechey C, SkinnerJ, Peters J & Christian
HC |
| |
|
|
| OC7 |
12:30 |
Sexually dimorphic glucocorticoid programming of the hypothalamo-pituitary-prolactin
axis |
| |
|
McArthur S, Siddique Z-L & Gillies GE |
| |
|
|
| OC8 |
12:45 |
Fetal programming of the endothelial nitric oxide pathway in man |
| |
|
Abbott LP, King A, Francis S, Gibson AT, Fraser RB & Newell-Price
J |
|
|
|
13:00 – 13:30 |
Wolfson Theatre |
|
|
Society for Endocrinology AGM |
| |
|
|
13:00 – 14:30 |
Osler/Long
Room |
|
|
Lunch |
| |
|
|
13:30 – 14:30 |
Library |
|
|
Attended Posters |
| |
|
|
14:30 – 16:30 |
Wolfson Theatre |
|
|
Symposium
2: Stressed mothers: causes and outcomes |
| |
|
Chair: Douglas A (Edinburgh) |
| |
|
|
| S9 |
14:30 |
Oxytocin and the cross-generational transmission of mothering and stress
responses |
| |
|
Pedersen C (Chapel Hill, USA) |
| |
|
|
| S10 |
15:00 |
Reproductive
hormones: involvement in maternal stress coping and anxiety |
| |
|
Neumann I (Munich, Germany) |
| |
|
|
| S11 |
15:30 |
Effects of pre-natal stress on behaviour and neuroendocrine activity
of pigs' offspring |
| |
|
Lawrence A (Edinburgh) |
| |
|
|
| S12 |
16:00 |
Endocrine-immune
bi-directionality in pregnancy: effects of stress and anxiety |
| |
|
Arck P (Berlin, Germany) |
| |
|
|
| 14:30 – 16:30 |
Sloane/Linacre Room |
| |
|
Oral Communications 2: Neuroendocrinology and reproduction |
| |
|
Chair: Buckingham J (London) & McNeilly A (Edinburgh) |
| |
|
|
| OC9 |
14:30 |
Tri-iodothyronine
directly regulates feeding |
| |
|
Martin NM, Kong WM, Smith KL, GardinerJV, Small CJ, Ghatei MA & Bloom
SR |
| |
|
|
| OC10 |
14:45 |
Subcutaneous administration of ghrelin and its effects on food intake
in man |
| |
|
Druce MR, Neary NM, Monteiro M, Small C, Ghatei M & Bloom
SR |
| |
|
|
| *OC11 |
15:00 |
Brain-derived
neurotrophic factor (BDNF) is a novel steroidogenic factor-1 (SF-1) target
gene in the ventromedial hypothalamus (VMH): implications for
obesity onset |
| |
|
Fowkes RC, Tran PV, Akana SF, Carey CR, Dallman MF & Ingraham
HA |
| |
|
|
| OC12 |
15:15 |
Macrophage migration inhibitory factor is released from pituitary folliculo-stellate-like
cells by endotoxin and dexamethasone and attenuates the steroid-induced inhibition
of interleukin 6 release |
| |
|
Tierney T, Patel R, Stead CS, Leng L, Bucala R & Buckingham
JC |
| |
|
|
| OC13 |
15:30 |
Reduced
expression of anti-Müllerian hormone (AMH) protein
in the androgenised sheep ovary |
| |
|
Bull L, Stubbs S, Birch R, Robinson J, Themmen AP, Visser JA, Groome
NP, Hardy K & Franks S |
| |
|
|
| OC14 |
15:45 |
Sickle Cell trait and gender influence Type 2 diabetic complications
in African patients |
| |
|
Kolawole BA, Ajayi AA & Ikem RT |
| |
|
|
| OC15 |
16:00 |
PGF2alpha-FP receptor signalling is a potential regulator of endometrial
vascular function |
| |
|
Sales KJ, Williams ARW, Anderson RA, NaorZ & Jabbour HN |
| |
|
|
| OC16 |
16:15 |
Sp1 and CREB promote nectin-2 transcription to regulate adheren's junctions
assembly in the testis |
| |
|
Lui WY, Sze KL & Lee WM |
| |
|
16:30 – 16:45 |
Osler/Long
Room |
|
|
Tea |
|
|
|
16:45 – 17:45 |
Wolfson Theatre |
|
|
Plenary lecture: Society
for Endocrinology European
Medal Lecture |
|
|
Chair: Bloom S (London) |
| |
|
|
S2 |
16:45 |
Neuroendocrine tumours: from bench to bed -
25 years experience and the future |
|
|
Oberg K (Uppsala, Sweden) |
| |
|
|
| ONCOLOGY STRAND |
| GENEROUSLY SUPPORTED BY NOVARTIS PHARMACEUTICALS
UK LTD |
| |
11:00 – 13:00 |
Wolfson Theatre |
|
|
Oncology Symposium 1: Neuroendocrine Tumours |
|
|
Chair: Caplin M (London)
|
| |
|
|
| S25 |
11:00 |
The
management of neuroendocrine tumours with radioactive octreotide |
| |
|
Grossman A (London) |
| |
|
|
| S26 |
11:30 |
New genetic causes of pheochromocytoma |
| |
|
Neumann H (Freiburg, Germany) |
| |
|
|
| S27 |
12:00 |
Genotype-Phenotype correlations in von Hippel-Lindau disease |
| |
|
Maher E (Birmingham) |
| |
|
|
| S28 |
12:30 |
Surgical aspects of medullary thyroid cancer treatment |
| |
|
Harrison B (Sheffield) |
|
|
|
| |
|
| 14:30 – 16:30 |
Seligman Theatre |
| |
|
Oncology Symposium 2: Endocrine aspects of breast cancer |
| |
|
Chair: Trainer P (Manchester) |
| |
|
|
| S29 |
14:30 |
New pure antioestrogens |
| |
|
Howell A (Manchester) |
| |
|
|
| S30 |
15:00 |
The role of oestrogens in the development of breast cancer |
| |
|
Reeves G (Oxford) |
| |
|
|
| S31 |
15:30 |
Endocrine treatment of breast cancer |
| |
|
Dowsett M (London) |
| |
|
|
| S32 |
16:00 |
IGFs and breast cancer risk |
| |
|
Renehan A (Manchester) |